# Container Closure Systems for Human Drugs and Biological Products - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/container-closure-systems-for-human-drugs-and-biological-products/5e2706fd-7b11-421f-95b3-dabf73b2a467

> FDA guidance document: Container Closure Systems for Human Drugs and Biological Products. Issue date: August 13, 2026. Get complete insights and analysis.

---

## Details

- Title: Container Closure Systems for Human Drugs and Biological Products
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2026-08-13
- Last Changed: 2026-08-13
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2026-D-7957">FDA-2026-D-7957</a>

## Related Documents

- [Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/use-of-bayesian-methodology-in-clinical-trials-of-drug-and-biological-products-draft-guidance-for-industry/8e9c345e-0994-47b3-8d6c-054f04ed937e)
- [Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products](https://www.keypedia.com/guidances/guidance-document/real-world-evidence-considerations-regarding-non-interventional-studies-for-drug-and-biological-products/48325e39-b445-4a53-8cc0-7483dcf3e352)
- [Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products](https://www.keypedia.com/guidances/guidance-document/considerations-for-the-design-and-conduct-of-externally-controlled-trials-for-drug-and-biological-products/9dafe0c9-19d4-48c0-a1ca-6b2a04a813ed)